Literature DB >> 28454474

Incidence trends in high-grade primary brain tumors in males and females.

Jonas Nilsson1,2,3, Georg Holgersson1,4, Tobias Carlsson4, Roger Henriksson2,5, Stefan Bergström1,4, Michael Bergqvist1,2,4.   

Abstract

The focus of the present review is to investigate whether there is a variation in the incidence rates between male and female patients with high-grade primary brain tumors and if there are altered incidence rates associated with the time at which they were diagnosed. Previous studies identified in internationally peer-reviewed journals were identified using a systematic search of the PubMed database. Due to the difficulties in data interpretation, studies that exclusively included patient data classified prior to the 2nd edition of the World Health Organization histological classification system of brain tumors were excluded. The overall incidence rates and incidence trends of male and female patients were analyzed separately. The mean age-adjusted overall incidence rate in the male population was 1.27 per 100,000 compared with 0.89 per 100,000 in the female population. The variance between the two genders differed and a Wilcoxon rank-sum test indicated that there was no significant difference in the incidence rate of high-grade primary brain tumors between males and females (P=0.3658). Furthermore, there was no significant difference in incidence rate trend between 1996-2004 and 2005-2010 for male or female populations (P=0.101 and P=0.472, respectively). The results from the present systematic review did not demonstrate a significant difference in incidence rate between the two genders. Therefore, the results from the current study are considered to be preliminary and further studies are required to elucidate this issue.

Entities:  

Keywords:  gender; high-grade brain tumors; incidence trends

Year:  2017        PMID: 28454474      PMCID: PMC5403298          DOI: 10.3892/ol.2017.5770

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

1.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

Authors:  Quinn T Ostrom; Haley Gittleman; Paul Farah; Annie Ondracek; Yanwen Chen; Yingli Wolinsky; Nancy E Stroup; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2013-11       Impact factor: 12.300

Review 2.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Authors:  Therese A Dolecek; Jennifer M Propp; Nancy E Stroup; Carol Kruchko
Journal:  Neuro Oncol       Date:  2012-11       Impact factor: 12.300

3.  Brain tumors in Sweden: data from a population-based registry 1999-2012.

Authors:  Thomas Asklund; Annika Malmström; Michael Bergqvist; Ove Björ; Roger Henriksson
Journal:  Acta Oncol       Date:  2014-11-10       Impact factor: 4.089

4.  Intracranial tumors in adult population of the Varazdin County (Croatia) 1996-2004: a population-based retrospective incidence study.

Authors:  Biserka Dobec-Meić; Slaven Pikija; Danijel Cvetko; Vladimir Trkulja; Leo Pazanin; Nenad Kudelić; Kresimir Rotim; Ivan Pavlicek; And Ruza Kostanjevec
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

Review 5.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

6.  Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003.

Authors:  Isabelle Deltour; Christoffer Johansen; Anssi Auvinen; Maria Feychting; Lars Klaeboe; Joachim Schüz
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

7.  The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children.

Authors:  Nicolas R Smoll; Katharine J Drummond
Journal:  J Clin Neurosci       Date:  2012-09-13       Impact factor: 1.961

8.  Incidence and relative survival of anaplastic astrocytomas.

Authors:  Nicolas R Smoll; Brett Hamilton
Journal:  Neuro Oncol       Date:  2014-04-09       Impact factor: 12.300

9.  Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010.

Authors:  Haley R Gittleman; Quinn T Ostrom; Chaturia D Rouse; Jacqueline A Dowling; Peter M de Blank; Carol A Kruchko; J Bradley Elder; Steven S Rosenfeld; Warren R Selman; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Cancer       Date:  2014-08-25       Impact factor: 6.860

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  2 in total

1.  Texture analysis of diffusion weighted imaging for the evaluation of glioma heterogeneity based on different regions of interest.

Authors:  Shan Wang; Meng Meng; Xue Zhang; Chen Wu; Ru Wang; Jiangfen Wu; Muhammad Umair Sami; Kai Xu
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

2.  Anti-epidermal growth factor receptor therapy for glioblastoma in adults.

Authors:  Adrian Lee; Malmaruha Arasaratnam; David Lok Hang Chan; Mustafa Khasraw; Viive M Howell; Helen Wheeler
Journal:  Cochrane Database Syst Rev       Date:  2020-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.